News Medical

Test document

This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...
ascopubs.org

A randomized open-label study of darbepoetin alfa administered every 3 weeks with or without parenteral iron in anemic subjects with nonmyeloid malignancies receiving chemotherapy

Does one person provide it all? Defining the social support of women with cancer Pts with adverse events - n (%) 46 (79) 49 (88) 95 (83) Pts with serious adverse events - n (%) 18 (31) 21 (38) 39 (34) ...
ascopubs.org

A phase 2 study to evaluate the efficacy of darbepoetin-alfa administered using an extended dose schedule versus weekly dosing in cancer patients with chemotherapy-induced anemia

Mean (SD) BL Hb (g/dL) 10.1 (0.9) 10.1 (0.8) Mean* (95% CL) change in Hb from BL to wk 13 (g/dL) [n] (available data) 1.3 (1.1, 1.5) [253] 1.2 (1.0, 1.3) [252] KM% (95% CL) pts who achieved target Hb ...